Imepitoin, also known as AWD 131-138, a novel antiepileptic drug for the treatment of canine idiopathic epilepsy. Imepitoin is a centrally acting anti-epileptic which crosses the blood brain barrier. It inhibits seizures via potentiation of the GABA a receptor-mediated inhibitory effects on the neurones. It also has weak calcium channel blocking effect which may contribute to its anticonvulsive properties.

Product information

CAS Number: 188116-07-6

Molecular Weight: 279.72

Formula: C13H14ClN3O2

Synonym:

Imepitoin

AWD131-138

Chemical Name: 1-(4-chlorophenyl)-4-(morpholin-4-yl)-2,5-dihydro-1H-imidazol-2-one

Smiles: O=C1N=C(CN1C1C=CC(Cl)=CC=1)N1CCOCC1

InChiKey: IQHYCZKIFIHTAI-UHFFFAOYSA-N

InChi: InChI=1S/C13H14ClN3O2/c14-10-1-3-11(4-2-10)17-9-12(15-13(17)18)16-5-7-19-8-6-16/h1-4H,5-9H2

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 ^oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 ^oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined

HS Tariff Code: 382200

Products are for research use only. Not for human use.